276 related articles for article (PubMed ID: 14694243)
1. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist.
Otsuka M; Takahashi H; Shiratori M; Chiba H; Abe S
Thorax; 2004 Jan; 59(1):31-8. PubMed ID: 14694243
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 2 receptor antagonist reduces bleomycin-induced pulmonary fibrosis in mice.
Waseda Y; Yasui M; Nishizawa Y; Inuzuka K; Takato H; Ichikawa Y; Tagami A; Fujimura M; Nakao S
Respir Res; 2008 May; 9(1):43. PubMed ID: 18500976
[TBL] [Abstract][Full Text] [Related]
3. Candesartan cilexetil reduces graft arteriosclerosis in aortic transplantation model in rat.
Zezina L; Larsson E; Fellström B
Transpl Immunol; 2001 Feb; 8(4):245-51. PubMed ID: 11316067
[TBL] [Abstract][Full Text] [Related]
4. Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.
Tuncer I; Ozbek H; Ugras S; Bayram I
Exp Toxicol Pathol; 2003 Sep; 55(2-3):159-66. PubMed ID: 14620537
[TBL] [Abstract][Full Text] [Related]
5. Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.
Noda M; Matsuo T; Fukuda R; Ohta M; Nagano H; Shibouta Y; Naka T; Nishikawa K; Imura Y
Kidney Int; 1999 Sep; 56(3):898-909. PubMed ID: 10469358
[TBL] [Abstract][Full Text] [Related]
6. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
7. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.
Zorad S; Dou JT; Benicky J; Hutanu D; Tybitanclova K; Zhou J; Saavedra JM
Eur J Pharmacol; 2006 Dec; 552(1-3):112-22. PubMed ID: 17064684
[TBL] [Abstract][Full Text] [Related]
8. Losartan attenuates bleomycin-induced pulmonary fibrosis in rats.
Yao HW; Zhu JP; Zhao MH; Lu Y
Respiration; 2006; 73(2):236-42. PubMed ID: 16330873
[TBL] [Abstract][Full Text] [Related]
9. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats.
Inscho EW; Imig JD; Deichmann PC; Cook AK
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S178-83. PubMed ID: 9892160
[TBL] [Abstract][Full Text] [Related]
10. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
Nishikawa K
J Hum Hypertens; 1998 May; 12(5):301-9. PubMed ID: 9655651
[TBL] [Abstract][Full Text] [Related]
12. [Studying the influence of Candesartan cilexetil on the lung fibrosis in rats exposed to silica].
Yin G; Zhu WY; Zhang H; Li YF; Zhang CL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Apr; 30(4):250-4. PubMed ID: 22804930
[TBL] [Abstract][Full Text] [Related]
13. Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats.
Khuman MW; Harikumar SK; Sadam A; Kesavan M; Susanth VS; Parida S; Singh KP; Sarkar SN
Toxicology; 2016 Dec; 374():29-41. PubMed ID: 27889505
[TBL] [Abstract][Full Text] [Related]
14. Nicorandil ameliorates bleomycin-induced pulmonary fibrosis in rats through modulating eNOS, iNOS, TXNIP and HIF-1α levels.
Kseibati MO; Shehatou GSG; Sharawy MH; Eladl AE; Salem HA
Life Sci; 2020 Apr; 246():117423. PubMed ID: 32057902
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
16. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
[TBL] [Abstract][Full Text] [Related]
17. Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetil.
Unger T
Blood Press Suppl; 2000; 1():14-8. PubMed ID: 11059630
[TBL] [Abstract][Full Text] [Related]
18. Losartan attenuates paraquat-induced pulmonary fibrosis in rats.
Guo F; Sun YB; Su L; Li S; Liu ZF; Li J; Hu XT; Li J
Hum Exp Toxicol; 2015 May; 34(5):497-505. PubMed ID: 25233898
[TBL] [Abstract][Full Text] [Related]
19. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
20. Preventive effect of irbesartan on bleomycin-induced lung injury in mice.
Tanaka J; Tajima S; Asakawa K; Sakagami T; Moriyama H; Takada T; Suzuki E; Narita I
Respir Investig; 2013 Jun; 51(2):76-83. PubMed ID: 23790735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
